PL1789412T3 - Krystaliczna zasada alfuzosyny - Google Patents

Krystaliczna zasada alfuzosyny

Info

Publication number
PL1789412T3
PL1789412T3 PL04770711T PL04770711T PL1789412T3 PL 1789412 T3 PL1789412 T3 PL 1789412T3 PL 04770711 T PL04770711 T PL 04770711T PL 04770711 T PL04770711 T PL 04770711T PL 1789412 T3 PL1789412 T3 PL 1789412T3
Authority
PL
Poland
Prior art keywords
alfuzosin base
hours
crystalline
base
solution
Prior art date
Application number
PL04770711T
Other languages
English (en)
Inventor
Reddy Bandi Parthasaradhi
Reddy Kura Rathnakar
Reddy Rapolu Raji
Reddy Dasari Muralidhara
Reddy Matta Ramakrishna
Original Assignee
Hetero Drugs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Drugs Ltd filed Critical Hetero Drugs Ltd
Publication of PL1789412T3 publication Critical patent/PL1789412T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicon Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Saccharide Compounds (AREA)
PL04770711T 2004-09-16 2004-09-16 Krystaliczna zasada alfuzosyny PL1789412T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IN2004/000292 WO2006030449A1 (en) 2004-09-16 2004-09-16 Crystalline alfuzosin base
EP04770711A EP1789412B1 (en) 2004-09-16 2004-09-16 Crystalline alfuzosin base

Publications (1)

Publication Number Publication Date
PL1789412T3 true PL1789412T3 (pl) 2008-10-31

Family

ID=36059740

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04770711T PL1789412T3 (pl) 2004-09-16 2004-09-16 Krystaliczna zasada alfuzosyny

Country Status (7)

Country Link
US (1) US20070100143A1 (pl)
EP (1) EP1789412B1 (pl)
AT (1) ATE394395T1 (pl)
DE (1) DE602004013644D1 (pl)
ES (1) ES2305848T3 (pl)
PL (1) PL1789412T3 (pl)
WO (1) WO2006030449A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005019227A1 (en) * 2003-08-22 2005-03-03 Orchid Chemicals & Pharmaceuticals Ltd Process for the preparation of cephalosporin antibiotic
WO2006090268A2 (en) * 2005-02-28 2006-08-31 Glenmark Pharmaceuticals Limited Processes for the preparation of alfuzosin and salts thereof and novel crystalline forms of alfuzosin
US20070105880A1 (en) * 2005-11-08 2007-05-10 Torrent Pharmaceuticals Limited Process for the preparation of alfuzosin
WO2007074364A1 (en) * 2005-12-26 2007-07-05 Aurobindo Pharma Limited Process for the preparation of alfuzosin
WO2008015525A2 (en) * 2006-07-31 2008-02-07 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of alfuzosin hydrochloride
WO2007063556A2 (en) * 2006-12-07 2007-06-07 Msn Laboratories Limited An improved and industrial process for the preparation of alfuzosin hydrochloride and its novel polymorphs
WO2008152514A2 (en) 2007-05-04 2008-12-18 Actavis Group Ptc Ehf Process for the preparation of alfuzosin and salts thereof
IT1390760B1 (it) * 2008-07-21 2011-09-23 Lundbeck Pharmaceuticals Italy Spa Metodo di preparazione di alfuzosin cloridrato anidro
CN108069945A (zh) * 2017-12-31 2018-05-25 威海贯标信息科技有限公司 一种阿夫唑嗪新晶型
CN114874223B (zh) * 2022-05-25 2023-12-22 宁夏东吴农化股份有限公司 一种从噁二嗪废水中提取乌洛托品的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2421888A1 (fr) * 1978-02-06 1979-11-02 Synthelabo Amides d'alkylene-diamines et leur application en therapeutique
US4354921A (en) * 1981-07-27 1982-10-19 Texaco Inc. Solvent dewaxing process
US4668768A (en) * 1985-11-25 1987-05-26 General Electric Company Anti-solvent precipitation process for isolating polymers from solution
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
GB0605688D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
US7923026B2 (en) * 2006-10-20 2011-04-12 Solvay Pharmaceuticals B.V. Embedded micellar nanoparticles

Also Published As

Publication number Publication date
ES2305848T3 (es) 2008-11-01
ATE394395T1 (de) 2008-05-15
US20070100143A1 (en) 2007-05-03
EP1789412B1 (en) 2008-05-07
WO2006030449A1 (en) 2006-03-23
DE602004013644D1 (de) 2008-06-19
EP1789412A1 (en) 2007-05-30

Similar Documents

Publication Publication Date Title
CA2555804A1 (en) Polymorphic form of imatinib mesylate and a process for its preparation
PL1789412T3 (pl) Krystaliczna zasada alfuzosyny
WO2009000442A3 (en) Processes for the preparation of pyrazoles
MX2008008447A (es) Proceso para la preparacion de imatinib.
CA2610105C (en) Process for the synthesis of organic compounds
WO2005107462A3 (en) Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate
MY134921A (en) Process for the industrial synthesis of strontium ranelate and its hydrates
PT1466947E (pt) Composto azo
ZA201003751B (en) Process for the synthesis of propargylated aminoindan derivatives
TW200726750A (en) Stilbene derivatives, light-emitting element and light-emitting device
WO2007062002A3 (en) Fluorescent brighteners and compositions thereof, methods of preparation and uses
MX2009010243A (es) Compuestos de quinolina apropiados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6.
ES2452940T3 (es) Procedimiento novedoso de preparación de base de imatinib
WO2009008287A1 (ja) 4-(トリクロロメチルチオ)アニリン類およびその製造方法、ならびに4-(トリフルオロメチルチオ)アニリン類の製造方法
PL375378A1 (pl) Nowy sposób wytwarzania syntetycznego związku pośredniego dla pestycydów
MX2007004638A (es) Proceso para la preparacion de pirazoles.
IL149526A0 (en) Process for the preparation of ketimines
WO2001027092A3 (en) Process to prepare aryltriazolinones and novel intermediates thereto
WO2005080329A3 (en) Process for manufacture of racemic carvedilol
TWI371449B (en) Conversion of 2-pyrazolines to ryrazoles using bromine
JP2003512370A5 (pl)
MX2008000011A (es) Procesos para preparar derivados de pirazol-o-glucosido y nuevos intermediarios de dichos procesos.
AU2003261853A1 (en) Process for preparing azo compound
WO2004020439A3 (en) Improved process for preparation of risperidone
CN100546979C (zh) 一种4-[4-(二乙基胺基)苯基]甲烯基-5-乙氧基-2,4-二氢-2-苯基-3h-吡唑-3-酮的制备方法